A year ago, on March 16th 2020, tight restrictions were enforced to control the spread of SARS-CoV-2, the coronavirus, in
Pivot Park Screening Centre (PPSC) is your optimal partner in early drug discovery. At PPSC we provide drug discovery services in the fields of assay development, lab automation, Ultra-High-Throughput Screening (uHTS) and hit-to-lead biological profiling, in order to find novel leads for drug development. PPSC is located at Pivot Park in the Netherlands, which focuses on pharmaceutical R&D. It is an inspiring campus for open innovation in life sciences. We are continuously expanding our early drug discovery know-how, compound library and services to add value to our vibrant client network and the pharmaceutical R&D community. Through this we help you accelerate drug discovery for a healthier society.
✔ Integrated approach for early drug discovery
✔ Handling of large customer compound libraries
✔ Big pharma-like uHTS set-up and top-notch read-out technologies
✔ Very experienced screening site for ELF & pharma-accounts
✔ Broad knowledge in different assay development-solutions
✔ From disease targets to high-quality starting points for drug development
Interested? Get in touch and we’ll help you accelerate your drug discovery.
In a paper recently published in the SLAS Discovery Journal of Biomolecular Screening, European Lead Factory (ELF) scientists from Pivot
register now Watch this webinar on 26 May at 16.00 hrs CET, to learn about: Lipinski rules, pains’ concerns and
The zebrafish (Danio rerio) is a tropical fish with a genetic structure surprisingly similar to ours. However, they’ve become a